[JJSimmons]

Still holding up. Very good sign!

[JJSimmons]

Love how it held up. Normally these sell off after big days.

[JJSimmons]

No kidding. I bought back in September and have doubled my money.

[SirCharChar]

WOO HOO!!!! THANK YOU JUNO!!!

[Awl416]

Announced today - 9b / $87

[stockstalk09]

I think someone just figured out why, a little front loading tipster caught some wind back then, but seems to have been a bit off on what strike price to pick, if they did get a leak, with what ever they make, they can request the SEC and Fed's to incrust diamonds into the handcuffs when they come to take them for a ride downtown.

[Talc Moan]

Not sure just saw it on the news yesterday.

[T695]

Wow, do you know the offer price?

[Talc Moan]

What a jump on Celgene buyout talks

JUNO

[north40000]

MSKCC/PPHM poster # 1651 at AACR in April 2017 highlights safety in pre-clinical CAR-T studies. Note conclusions.

[jr881]

JUNO is also working on SOLID tumors with their Car T model.This down the road will be a larger market and change the way we treat cancer.

[ITMS]

$JUNO Hits Support For Technical Bounce Trade Here...

Shares of Juno Therapeutics Inc (NASDAQ:JUNO) have fallen sharply over the last two trading days. On a technical basis, the biotech hit major support when it broke through $46.00. This is a bounce level for investors looking for a quick couple day bounce. Look for a snap back to $50 in the coming days.




Gareth Soloway
InTheMoneyStocks

[stocktrademan]

JUNO buy 56.70

















normal chart




log chart

[zerowinner]

Someone bought 1000 May 2018 $85 calls for about $2.15anyone have a clue why?

[Easymoneyman00]

Sir char char, how many deaths has JUNO had during these trials? Very toxic stuff ! I hope they don't try and cover up anymore deaths . They sure forgot to mention the last 2 they had until they were called out on it? Good Luck just can't believe they went to $20 and are now at close to $60 with so many deaths caused by there treatment? Crazy!

[girlfriend]

$56.12 is where I got 2/3 out here!

[SirCharChar]

Climb baby! Climb higher!

[Stockstrodamus]

My guess is that JUNO will slowly creep to 47.04. Then will test Friday.

[Stockstrodamus]

Run baby run

[girlfriend]

JUNO at 45.40 here trying to breakout of its recent 41-45 channel. Lets go!

[Stockstrodamus]

JUNOOOOOOOOOO!!!!

$$$$$

BUY BUY BUY BUY

[SirCharChar]

So much going on and this board is dead. The future looks so bright.

[Avispa]

https://seekingalpha.com/news/3292381-buying-continues-juno-therapeutics-shares-16-percent

[moniluv]

There's a gap that needs to be filled...not sure when another PR will be out tho.

[buckmaster6985]

I'm up over a grand in this stock. Should I time it or hold longer?

[DONTSELLFROM_FEAR]

MACD FORMS BULLISH CROSSOVER RSI LOW ADX SHOWS STRONG TREND..COULD HIT 25.00 SOON

[Hypi]

I hate to gloat, but told you so about this being done.

[stocktrademan]

JUNO bearish 23.01

[ANIA77]

Yeah I agree. All these bio ticks usually get hit by a wave of class lawsuits shortly after bad news.. which usually causes additional panic on market and father drop in pps. My bid is lower.
JUNO

[T695]

This going down a lot further IMO

[T695]

Two more patients died, I would wait awhile to let that soak in before buying

[ANIA77]

JUNO could be a good buy here..
Though it's possible it will dip below $20 when lawsuits start hitting wires again soon
Have a bid in..
JUNO

[MARINO]

Marino was wrong. Not $30 but $33 this week

[DITRstocks]

boom

[MARINO]

JUNO easy $30 this week

[MARINO]

Marino in today at $28.40

[TREND1]

JUNO DAY

[ANIA77]

Juno on fire

[growacet]

Sorry for the dupe...double clutched

[growacet]

Blog post on JUNO lawsuit....

Asks the question: Is Ziopharm next? Also mentions KITE:

http://www.avoidthebag.com/2016/07/juno-therapeutics-being-sued-is.html

[Hypi]

CELG looking at alternative approaches and do realize there is no exact science. As TREND1 says about other stocks I own or follow "stock price tells the story." The same could be said for JUNO.

http://www.fiercebiotech.com/biotech/jounce-nabs-first-big-deal-2-6b-i-o-tie-up-celgene

Still like the technology just not sure I like this particular company. Typical biotech huge risk, but huge reward potential. No position, but watching closely for possible entry.

[TREND1]

Thanks

[ANIA77]

"Our JCAR017 plans remain on track. We expect to be able to have our first approval in the United States as early as 2018," Bishop said."

"Although we have experienced a setback in the ROCKET trial with the clinical hold…we are optimistic that we will achieve results comparable to those in the phase I trial. These results should provide the basis for an accelerated approval," according to Bishop."

JUNO

[Hypi]

No current position, but did have some puts when it tanked from $42 to $28 on PhaseII trial halt and I sold them at that time. I'm actually looking to get back in long, but was thinking we might see previous lows in the $22-$24 range. Probably missed that one, but a believer in the technology.

I only bought puts because I thought it was overvalued and felt the IBB was under pressure 2-3 weeks ago. Now the market if making new highs (though I'm not sold on a break out of the indexes that have transpired in the last week. Sitting and watching for the time being.

[TREND1]

*****AML Therapies: Seattle Genetics Vs. GlycoMimetics

ALSO JUNO MENTIONED

Jul. 15, 2016 8:10 AM ET
About: GlycoMimetics (GLYC), SGEN, Includes: JUNO


William Meyers
Follow (1,085 followers)

Long only, tech, biotech, research analyst


Summary


•Acute Myeloid Leukemia is very difficult to treat successfully.

•Seattle Genetics SGN-CD33A started a Phase 3 trial.

•GlycoMimetics GMI-1271 started Phase 2 trial.

•There are other competitors, but it is unlikely AML will be 100% cured by any one therapy.



http://seekingalpha.com/article/3988622-aml-therapies-seattle-genetics-vs-glycomimetics?ifp=0&app=1

[TREND1]

Hypi JUNO is working on a product that does not exist.

That is why 3 people (all under 25) can die, but the FDA still approves
resumption of phase 2 trial.

It will save lives when approved.

[TREND1]

***** JUNO WEEKLY NICE ACTING STOCK TO WEEKLY TREND LINES.